Insider Trading Activity Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) – Director Bought 20,000 shares of Stock

0

Insider Trading Activity For Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

Donald A Denkhaus , Director of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) reportedly Bought 20,000 shares of the company’s stock at an average price of 3.75 for a total transaction amount of $75,000.00 SEC Form

Insider Trading History For Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

  • On 11/15/2012 Philip H Coelho, Director, bought 24,000 with an average share price of $0.41 per share and the total transaction amounting to $9,840.00.
  • On 11/15/2012 Patrick J Mcenany, CEO, bought 100,000 with an average share price of $0.42 per share and the total transaction amounting to $42,000.00.
  • On 12/8/2012 Biomarin Pharmaceutical Inc, Major Shareholder, bought 5,000,000 with an average share price of $0.75 per share and the total transaction amounting to $3,750,000.00.
  • On 12/17/2012 Patrick J Mcenany, CEO, bought 100,000 with an average share price of $0.45 per share and the total transaction amounting to $45,000.00.
  • On 2/19/2013 Patrick J Mcenany, CEO, bought 50,000 with an average share price of $0.46 per share and the total transaction amounting to $23,000.00.
  • On 10/21/2013 Patrick J Mcenany, CEO, bought 50,000 with an average share price of $1.59 per share and the total transaction amounting to $79,500.00.
  • On 10/21/2013 Charles B O’keeffe, Director, bought 10,000 with an average share price of $1.84 per share and the total transaction amounting to $18,400.00.
  • Analyst Ratings History For Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

    • On 11/1/2017 Roth Capital Set Price Target of rating Buy with a price target of $5.00
    • On 11/29/2017 SunTrust Banks Reiterated Rating Buy with a price target of $6.00
    • On 12/1/2017 Piper Jaffray Companies Set Price Target of rating Positive ➝ Buy with a price target of $8.00
    • On 3/15/2018 HC Wainwright Reiterated Rating Buy with a price target of $6.00

    Recent Trading Activity for Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)
    Shares of Catalyst Pharmaceuticals Inc closed the previous trading session at 3.92 up +0.09 2.35% with 3.809999942779541 shares trading hands.